ArticleBone marrow transplantation2024

High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas.

Jeremy Ramdial et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.